Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Dexmedetomidine
(D00514)		[1] Dexmedetomidine[2] Dexmedetomidine (D00514),
Dexmedetomidine hydrochloride 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[15] 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
2Dexmedetomidine 1
(D00514)		[1] Dexmedetomidine[2] Dexmedetomidine (D00514),
Dexmedetomidine hydrochloride 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 280 💬
3Dexmedetomidine 2
(D00514)		[1] Dexmedetomidine[2] Dexmedetomidine (D00514),
Dexmedetomidine hydrochloride 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 280 💬
4Dexmedetomidine 3
(D00514)		[1] Dexmedetomidine[2] Dexmedetomidine (D00514),
Dexmedetomidine hydrochloride 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 280 💬
5Dexmedetomidine group
(D00514)		[1] Dexmedetomidine[2] Dexmedetomidine (D00514),
Dexmedetomidine hydrochloride 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 70 💬
6Dexmedetomidine HCL 100 MCG/ML INJ
(D00514)		[1] Dexmedetomidine[2] Dexmedetomidine (D00514),
Dexmedetomidine hydrochloride 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 215 💬
7Dexmedetomidine hydrochloride
(D00514)		[1] Dexmedetomidine[2] Dexmedetomidine (D00514),
Dexmedetomidine hydrochloride 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 70 💬
8Dexmedetomidine hydrochloride infusion
(D00514)		[1] Dexmedetomidine[2] Dexmedetomidine (D00514),
Dexmedetomidine hydrochloride 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 6 💬
9Dexmedetomidine injection
(D00514)		[1] Dexmedetomidine[2] Dexmedetomidine (D00514),
Dexmedetomidine hydrochloride 💬 		[3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 70 💬
10Dexmedetomidine with ropivacaine
(D00514)		[2] Dexmedetomidine,
Ropivacaine		[4] Dexmedetomidine (D00514),
Dexmedetomidine hydrochloride ,
Ropivacaine hydrochloride ,
Ropivacaine 💬 		[8] ADRA2A,
ADRA2B,
ADRA2C,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		[7] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway 💬[1] 70 💬
11Fentanyl (LOW dose) + dexmedetomidine
(D00514)		[1] Fentanyl[3] Fentanyl ,
Fentanyl citrate ,
Fentanyl hydrochloride 💬 		[1] OPRM1 💬 [5] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 215 💬
12Scopolamine, atropine, edaravone and dexmedetomidine
(D00514)		[2] Edaravone,
Scopolamine		[2] Scopolamine ,
Edaravone 💬 		[5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		[14] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 2 💬